InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Bobulsky Susan. Director active across 1 company, notably Adaptive Biotechnologies Corp. In total, 10 reports have been published. Breakdown: 0 buy · 6 sells. Total volume traded: €749k. History available since 4 March 2024. The latest transaction was disclosed on 16 July 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations
Susan BOBULSKY is a declarant linked to Adaptive Biotechnologies Corp, where she holds the role of Chief Commercial Officer, MRD. She has 6 filings in total, and in the sampled recent filings between 2024-03-06 and 2026-06-29, sales total 170478 EUR and the modal transaction nature is Cession.